Glucose-responsive hepatic insulin gene therapy of spontaneously diabetic BB/Wor rats.


Hepatic insulin gene therapy (HIGT) ameliorates hyperglycemia in multiple rodent models of diabetes mellitus, with variable degrees of glucose control. We demonstrate here that adenoviral delivery of a glucose-regulated transgene into rat hepatocytes produces near-normal glycemia in spontaneously diabetic BB/Wor rats without administration of exogenous… (More)


  • Presentations referencing similar topics